Navigation Links
Diplomat Specialty Pharmacy: Only Vendor to Receive URAC Accreditation for Both Disease Management and Drug Therapy Management
Date:7/7/2009

view and consideration for accreditation by URAC's Accreditation Committee.

URAC's accreditation standards promote core organizational excellence and a clear focus on patient safety, outcomes measurement and quality improvement. Meeting URAC's standards means Diplomat strives for appropriate therapeutic outcomes for patients through improved medication use; reduces the incidence of adverse events; and reports to an oversight committee.

URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit www.urac.org

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest privately held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's, Hemophilia, Growth Hormone and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patient
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy
2. Diplomat Specialty Pharmacy Expands National Growth Hormone Patient Care Program - Hires Denise Piro, RN, BSN
3. Diplomat Specialty Pharmacy - A Thriving Michigan Based Healthcare Company
4. Animal Dermatology Clinic - San Diego Announces Dr. Brett Wildermuth, DVM, Achieves Diplomate Status With the American College of Veterinary Dermatology
5. Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services
6. Specialty Hospitals of America Accepts First Patients in New Long Term Critical Care Hospital Located in South East Washington
7. Kevin Niksarli, M.D. of Manhattan Lasik Center is to Discuss the iLASIK Procedure on AMWC Subspecialty Day Meeting on 7/1/2009
8. West Pharmaceutical Services to Present at the 2009 UBS Global Specialty Pharmaceuticals Conference
9. Specialty care costs for patients with bipolar disorder are higher than diabetes and other chronic diseases
10. Specialty Care Costs for Patients With Bipolar Disorder Are Higher Than Diabetes and Other Chronic Diseases
11. Axium Healthcare Picks CPR+ as Its Specialty Pharmacy Management Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... infectious HIV-1 is widely thought to be the major ... persons. U.S. Military HIV Research Program (MHRP) researchers, however, ... particles can bind to the surface of red blood ... donors. The results were published today in PLoS ... The lead investigators, Dr. Zoltan Beck and Dr. Carl ...
(Date:12/15/2009)... how to make an AIDS vaccine have found the ... the immune system can indeed produce cells with the ... the same time, the immune system works equally hard ... have a chance to mature. , "These studies show ... disease is under the control of immunological tolerance," said ...
(Date:12/15/2009)... users to control the volume without compromising sound-quality or comfort. ... ... 15, 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing ... in three different skin-tone colors. "As a big fan of ... I was looking for a way to continue my active ...
(Date:12/15/2009)... Management Systems (HRMS), announced in a direct response to demand ... (APSS) to its suite of HR software, to increase productivity ... ... Mahwah, NJ (PRWEB) December 15th 2009 -- Humanic ... announced in a direct response to demand for increased technology ...
(Date:12/15/2009)... Better mental health care still needed for those with ... News) -- Suicides among people in Switzerland who were ... the introduction of highly active antiretroviral therapy in 1996, ... that causes AIDS. , Yet despite the decrease, the ... higher than that of the general population, according to ...
Breaking Medicine News(10 mins):Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:Humanic Design is Pleased to Announce Application Self Service (APSS) to its Product Suite to Empower Organizations with Automation 2Health News:HIV Therapy Linked to Fewer Suicides 2
... 50 are more likely to die from suicide than any ... ,A study of public hospital emergency departments in Perth ... the emergency departments of seven Perth hospitals between June 2000 ... suicide within weeks of being discharged. The sample included terminally ...
... organisms, are exposed to ever-changing environments, oxidative stress, ... to defend themselves against all these insults, gain ... simply by ‘stealing’ genetic information from other better-adapted ... sex, known as horizontal gene transfer. ...
... Central Bureau of Investigation (CBI) carried out simultaneous raids ... Delhi and three other cities on Monday.// ,The ... the national capital, an official of the investigating agency ... Safdarjung Hospital's gynaecology department, and Uma Goel of Sucheta ...
... can cure tumors in animals and humans.,Scientists led by Moira ... an aggressive //form of brain cancer after finding the method ... of the herpes virus was injected into the patient who ... But, eight years later he is still alive and his ...
... Hospitals Group plans to invest Rs 350 crore to add ... new addition of 1800 beds, Apollo Group's total capacity would ... ,"There is a plan for adding 800 beds through management ... Hospitals Group Director Finance, Suneeta Reddy, said here on the ...
... that can lead to a multitude of complications if ... suggests the possibility of using tea as a form ... has been found to prevent the incidence of cataracts, ... diabetics worldwide. , ,Researchers developed special rats with ...
Other Medicine News:Health News:Bacteria Evolve Armamentarium Against Antibiotics By ‘Stealing’ Gen 2
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Systemic Lupus ... Market Forecasts to 2015 ,, ... Lupus Erythematosus - Drug Pipeline Analysis ... Summary ,, GlobalData, the ...
(Date:12/15/2009)... December 15 EnzySurge Ltd.,(EnzySurge), a ... chronic,wound management market, announced today that it ... Drug Administration (FDA) to market its new,SilverStream(TM) ... cleared,DermaSept, an Over-the-Counter version of the SilverStream ... is the developer of the DermaStream(R) product ...
(Date:12/15/2009)... 15 NxStage Medical, Inc. (Nasdaq: ... products, today announced that a group of its ... embarking on a week-long, conventional (non-dialysis) Caribbean cruise ... cruise, dubbed the "2010 Freedom Cruise: We,re Taking ... on January 3, 2010 and returns on January ...
Breaking Medicine Technology:Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 1Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 2Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 3Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 4Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 5Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 6Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 1InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 13PDI Reports 2009 Third Quarter Financial Results 6023 1PDI Reports 2009 Third Quarter Financial Results 6023 2PDI Reports 2009 Third Quarter Financial Results 6023 3PDI Reports 2009 Third Quarter Financial Results 6023 4PDI Reports 2009 Third Quarter Financial Results 6023 5PDI Reports 2009 Third Quarter Financial Results 6023 6PDI Reports 2009 Third Quarter Financial Results 6023 7PDI Reports 2009 Third Quarter Financial Results 6023 8PDI Reports 2009 Third Quarter Financial Results 6023 9PDI Reports 2009 Third Quarter Financial Results 6023 10PDI Reports 2009 Third Quarter Financial Results 6023 11
... BALTIMORE, Dec. 10 Data by Dr. J. Bart Classen ... Research & Reviews provides further evidence that epidemics of ... to immunization. Classen previously published proof vaccines are causing an ... , The new data as well ...
... results from a Phase 1/2 study of perifosine in ... relapsed from or refractory to bortezomib , ... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... in combination with bortezomib (+/- dexamethasone) in patients with ...
Other Medicine Technology:Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: